Pivekimab Sunirine

Near Add Your Location

Accepting patients

PVEK (IMGN632)

Phase 1 Study of FLAG-Ida With Pivekimab Sunirine (PVEK [IMGN632]) for Adults With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Learn more
  • Antibody Drug Conjugate (ADC)
  • CD123
  • Phase 1